Rankings
▼
Calendar
BMY Q1 2016 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena
BMY
Bristol-Myers Squibb Company
$121B
Q1 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$4.4B
Gross Profit
$3.3B
76.0% margin
Operating Income
$1.1B
25.3% margin
Net Income
$1.2B
27.2% margin
EPS (Diluted)
$0.71
Cash Flow
Operating Cash Flow
-$228M
Free Cash Flow
-$470M
Stock-Based Comp.
$47M
Balance Sheet
Total Assets
$31.9B
Total Liabilities
$17.3B
Stockholders' Equity
$14.4B
Cash & Equivalents
$2.6B
Revenue Segments
Eliquis
$734M
17%
Opdivo
$704M
16%
Mature Products And All Other
$535M
12%
Orencia
$475M
11%
Hepatitis C Portfolio
$427M
10%
Sprycel
$407M
9%
Baraclude
$291M
7%
Sustiva Franchise
$273M
6%
Yervoy
$263M
6%
Reyataz
$221M
5%
Abilify
$33M
1%
Empliciti
$28M
1%
← FY 2016
All Quarters
Q2 2016 →
